Multiple myeloma refers to blood cancer found within the plasma cells of bone marrow. It is a rare cancer, affecting less than one percent of the U.S. population. Currently, there is no cure for multiple myeloma, but there are treatment options that can help people live longer, healthier lives. Stem cell transplant is a standard of care for eligible patients. However, over half of patients newly diagnosed with multiple myeloma are not eligible for transplant due to age or other major health problems, such as heart, lung, liver, or kidney disease. And studies have shown people who are ineligible for transplant have a lower survival rate.
Listen as Dr. Yee provides treatment planning options available to patients who are ineligible for transplant.
“Overtime these patients can experience significant improvements in quality of life…they can go back to their normal routine.”
“Ultimately, there needs to be a shared decision between the patient and the care team in terms of what their goals and priorities are.”
– Andrew Yee, MD
Andrew Yee, MD
Clinical Director
Center for Multiple Myeloma at Massachusetts General Hospital
Assistant Professor of Medicine
Harvard Medical School, Boston, MA
This podcast was generously supported by Janssen Oncology. This podcast was developed through a collaboration between The Association of Community Cancer Centers and The Leukemia & Lymphoma Society.
Resources:
ACCC’s Multiple Myeloma Web Page
HealthTree Foundation
Leukemia & Lymphoma Society
National Cancer Institute
Social Determinants of Health in Metastatic Breast Cancer
Overcoming Barriers to Holistic Survivorship Care for Immunotherapy Patients
Integrating Genetic Counselors in Routine Genitourinary Care
A Multidisciplinary Approach to Anemia Management in High-Risk MDS and AML
Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer
Highlights from the ACCC Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education
Care Action Plans for People with Cancer
Beyond the Brush: Navigating Dental Care in Head & Neck Cancer
Navigating the Operational Challenges of Treatment with Bispecific Antibodies
Policy Perspectives on Biomarker Testing Coverage for 2024
Open Enrollment: Best Practices for End-of-Year Prep
Disparities in Accessing Care for AML Patients: Challenges and Solutions
Clarifying the Role of Maintenance Therapy
A Conversation With ACCC’s Outgoing and Incoming Presidents at the ACCC 50th Annual Meeting and Cancer Center Business Summit
LIVE from AMCCBS: White House Update
LIVE from AMCCBS: Capitol Hill Update
LIVE from AMCCBS: Institute for Comprehensive Cancer Care Services
LIVE from AMCCBS: New Payments for Patient Navigation
LIVE from AMCCBS: Financial Advocacy Resources
Making the Case for Head & Neck Cancer Patient Care Navigators
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain